Skip to main content
Print Save

Watson 667 (Divalproex Sodium Delayed Release 500 mg)

Pill with imprint Watson 667 is Red, Elliptical/Oval and has been identified as Divalproex Sodium Delayed Release 500 mg. It is supplied by Watson Laboratories, Inc.

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Watson 667

Divalproex Sodium Delayed Release

Imprint
Watson 667
Strength
500 mg
Color
Red
Size
19.00 mm
Shape
Elliptical/Oval
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
62037-0667
Inactive Ingredients
candelilla wax, cellacefate, silicon dioxide, croscarmellose sodium, dextrates, FD&C Red No. 40, hydroxypropyl cellulose, hypromellose 2910 (15 mPa.s), ferrosoferric oxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, propylene glycol, titanium dioxide, triacetin, aluminum oxide

Note: Inactive ingredients may vary.

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Related images for "Watson 667"

Pill 667 400 WATSON White Elliptical/Oval is Etodolac
Etodolac

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer